| |
Article Title |
Author(s) |
Type |
Pages |
|
Endoscopic Mucosal Resection in the Management of Esophageal Neoplasia: Current Status and Future Directions
September 2010 (Vol. 8 | No. 9 | Pages 743-754)
Endoscopic mucosal resection has expanded the role of the gastroenterologist in the management of esophageal neoplasia from screening and diagnosis to staging and endoscopic treatment. Its rise to pro...
|
Vikneswaran Namasivayam,
Kenneth K. Wang,
Ganapathy A. Prasad
|
Review article

|
pages 743-754
|
|
Health-Related Quality of Life in Patients With Hepatocellular Carcinoma: A Systematic Review
July 2010 (Vol. 8 | No. 7 | Pages 559-564.e10)
Background & Aims: This systematic review was conducted to identify the following: (1) generic and disease-specific measures used to assess health-related quality of life (HRQOL) in patients with ...
|
Sheng–Yu Fan,
Christine Eiser,
Ming–Chih Ho
|
Review article
|
pages 559-564.e10
|
|
Gastrointestinal and Hepatic Complications of Sickle Cell Disease
June 2010 (Vol. 8 | No. 6 | Pages 483-489)
Sickle cell disease (SCD) is an autosomal recessive abnormality of the β-globin chain of hemoglobin (Hb), resulting in poorly deformable sickled cells that cause microvascular occlusion and hemolytic ...
|
Ellen C. Ebert,
Michael Nagar,
Klaus D. Hagspiel
|
Review article
|
pages 483-489
|
|
Systematic Review and Meta-analysis of the Prevalence of Irritable Bowel Syndrome in Individuals With Dyspepsia
May 2010 (Vol. 8 | No. 5 | Pages 401-409)
Background & Aims: Dyspepsia and irritable bowel syndrome (IBS) are common conditions that can coexist in patients. We performed a systematic review and meta-analysis to estimate prevalence of IBS...
|
Alexander C. Ford,
Avantika Marwaha,
Allen Lim,
Paul Moayyedi
|
Review article
|
pages 401-409
|
|
Systematic Review of the Quality of Patient Information on the Internet Regarding Inflammatory Bowel Disease Treatments
April 2010 (Vol. 8 | No. 4 | Pages 322-328)
Background & Aims: Patients use the Internet as a resource for information about their diseases. A systematic review evaluating the quality of information available for inflammatory bowel disease ...
|
Morgan Langille,
André Bernard,
Chris Rodgers,
Stephanie Hughes,
Des Leddin,
Sander Veldhuyzen van Zanten
et al.
|
Review article
|
pages 322-328
|
|
Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis
March 2010 (Vol. 8 | No. 3 | Pages 235-244)
Background & Aims: As the risk of esophageal adenocarcinoma (EAC) and mortality in patients with Barrett's esophagus (BE) are important determinants of the potential yield and cost-effectiveness o...
|
Marjolein Sikkema,
Pieter J.F. de Jonge,
Ewout W. Steyerberg,
Ernst J. Kuipers
|
Review article

|
pages 235-244
|
|
Effects of Helicobacter pylori Eradication on Early Stage Gastric Mucosa–Associated Lymphoid Tissue Lymphoma
February 2010 (Vol. 8 | No. 2 | Pages 105-110)
Background & Aims: Different remission rates of gastric low-grade, B-cell, mucosa–associated lymphoid tissue (MALT) lymphoma have been reported after Helicobacter pylori eradication. We assessed t...
|
Angelo Zullo,
Cesare Hassan,
Francesca Cristofari,
Alessandro Andriani,
Vincenzo De Francesco,
Enzo Ierardi,
Silverio Tomao,
Manfred Stolte,
Sergio Morini,
Dino Vaira
et al.
|
Review article
|
pages 105-110
|
|
Acute Acalculous Cholecystitis: A Review
January 2010 (Vol. 8 | No. 1 | Pages 15-22)
Although recognized for more than 150 years, acute acalculous cholecystitis (AAC) remains an elusive diagnosis. This is likely because of the complex clinical setting in which this entity develops, th...
|
Jason L. Huffman,
Steven Schenker
|
Review article
|
pages 15-22
|
|
Prevalence of Adenomas and Colorectal Cancer in Average Risk Individuals: A Systematic Review and Meta-analysis
December 2009 (Vol. 7 | No. 12 | Pages 1272-1278)
Background & Aims: There is an extensive yet inconsistent body of literature reporting on the prevalence of adenomatous polyps (adenomas) and colorectal cancer among average risk individuals. The ...
|
Steven J. Heitman,
Paul E. Ronksley,
Robert J. Hilsden,
Braden J. Manns,
Alaa Rostom,
Brenda R. Hemmelgarn
et al.
|
Review article
|
pages 1272-1278
|
|
Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-analysis
December 2009 (Vol. 7 | No. 12 | Pages 1279-1286)
Background & Aims: Small intestinal bacterial overgrowth (SIBO) has been proposed as an etiologic factor in irritable bowel syndrome (IBS), but evidence is conflicting. We conducted a systematic r...
|
Alexander C. Ford,
Brennan M.R. Spiegel,
Nicholas J. Talley,
Paul Moayyedi
|
Review article
|
pages 1279-1286
|
|
Evidence for Endoscopic Ulcers as Meaningful Surrogate Endpoint for Clinically Significant Upper Gastrointestinal Harm
November 2009 (Vol. 7 | No. 11 | Pages 1156-1163)
Background & Aims: Surrogate endpoints are biomarkers intended to substitute for a clinical endpoint. Are endoscopic ulcers a useful surrogate endpoint for a biological progression to clinical end...
|
Andrew Moore,
Ingvar Bjarnason,
Byron Cryer,
Luis Garcia–Rodriguez,
Larry Goldkind,
Angel Lanas,
Lee Simon
et al.
|
Review article
|
pages 1156-1163
|
|
Efficacy of Chronic Hepatitis C Therapy in Community-Based Trials
October 2009 (Vol. 7 | No. 10 | Pages 1028-1036)
Prospective, randomized, controlled, phase 3 clinical trials establish pegylated interferon (PEG-IFN) alfa plus ribavirin as the standard of care for patients with chronic hepatitis C. Such clinical t...
|
Paul Marotta,
Dietrich Hueppe,
Elmar Zehnter,
Paul Kwo,
Ira Jacobson
et al.
|
Review article
|
pages 1028-1036
|
|
Treatment Options for Patients With Chronic Hepatitis C Not Responding to Initial Antiviral Therapy
September 2009 (Vol. 7 | No. 9 | Pages 921-930)
Pegylated interferon alfa-2a or alfa-2b plus ribavirin for 24 or 48 weeks, depending on genotype, is the standard of care for patients with chronic hepatitis C. However, up to 50% of patients are nonr...
|
Ira M. Jacobson
|
Review article
|
pages 921-930
|
|
What Makes Individuals With Gastroesophageal Reflux Disease Dissatisfied With Their Treatment?
August 2009 (Vol. 7 | No. 8 | Pages 816-822)
Background & Aims: Despite the efficacy of proton pump inhibitors (PPIs) as therapeutics for patients with gastroesophageal reflux disease (GERD) in randomized controlled trials, a number of studi...
|
Peter Bytzer
|
Review article
|
pages 816-822
|
|
Endoscopic Therapy for Barrett's Esophagus
July 2009 (Vol. 7 | No. 7 | Pages 716-720)
Recent retrospective cohort data and a prospective randomized sham controlled trial have clearly documented the impact of endoscopic ablation therapy on dysplasia and Barrett's esophagus (BE). The cli...
|
Richard E. Sampliner
|
Review article
|
pages 716-720
|
|
Health-Related Quality of Life in Patients With Barrett's Esophagus: A Systematic Review
June 2009 (Vol. 7 | No. 6 | Pages 613-623)
Background & Aims: Barrett's esophagus (BE) affects approximately 10% of patients with chronic gastroesophageal reflux disease (GERD). Patients with BE are at risk for reduced health-related quali...
|
Seth D. Crockett,
Quinn K. Lippmann,
Evan S. Dellon,
Nicholas J. Shaheen
|
Review article
|
pages 613-623
|
|
Treatment of Chronic Constipation: Current Pharmacologic Approaches and Future Directions
May 2009 (Vol. 7 | No. 5 | Pages 502-508)
Chronic constipation is a common condition that affects up to 27% of the population. Dietary and lifestyle measures are usually the first-line therapy, but if these fail to have an effect then a varie...
|
Jan Tack,
Stefan Müller–Lissner
|
Review article
|
pages 502-508
|
|
A Systematic Review of the Definitions, Prevalence, and Response to Treatment of Nocturnal Gastroesophageal Reflux Disease
April 2009 (Vol. 7 | No. 4 | Pages 372-378)
Background & Aims: More than half of patients with chronic gastroesophageal reflux (GERD) report nocturnal symptoms. We performed systematic literature review to define nocturnal heartburn and to ...
|
Lauren B. Gerson,
Ronnie Fass
|
Review article
|
pages 372-378
|
|
Multidisciplinary Approach to Diagnosis and Management of Intraductal Papillary Mucinous Neoplasms of the Pancreas
March 2009 (Vol. 7 | No. 3 | Pages 259-269)
Intraductal papillary mucinous neoplasms have gained recognition in recent years as premalignant precursors to pancreatic cancer that enable early detection and often are found incidentally at imaging...
|
Dushyant V. Sahani,
Dana J. Lin,
Aradhana M. Venkatesan,
Nisha Sainani,
Mari Mino–Kenudson,
William R. Brugge,
Carlos Fernandez–Del–Castillo
et al.
|
Review article
|
pages 259-269
|
|
Hepatitis C in the Elderly: Epidemiology, Natural History, and Treatment
February 2009 (Vol. 7 | No. 2 | Pages 128-134)
Hepatitis C continues to be a major public health problem affecting approximately 3% of the global population. According to the World Health Organization, an estimated 170 million people have chronic ...
|
Ayse L. Mindikoglu,
Ram R. Miller
|
Review article
|
pages 128-134
|